Plain-English translation of NCT07784907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new way to treat knee osteoarthritis pain by injecting hyaluronic acid combined with platelet-rich plasma (PRP)—a concentrate made from your own blood that contains natural healing factors. Half of the participants will receive this combination injection, while the other half will receive hyaluronic acid alone. Researchers want to see if adding the blood-derived growth factors makes the treatment work better for reducing knee pain and improving how well your knee functions.
Hyaluronic acid injections are already used to treat knee osteoarthritis, but they don't work well enough for everyone. Platelet-rich plasma contains substances that may help reduce inflammation and support tissue healing, so combining the two treatments might provide better pain relief and lasting improvement than either one alone.
You likely qualify if…
You likely don't qualify if…
You will receive a single injection into your knee joint. If you are randomly assigned to the combination group, a small amount of your blood will be drawn and processed to create the platelet-rich plasma, which is then combined with hyaluronic acid before injection. If you are in the standard group, you will receive hyaluronic acid alone. After the injection, you will complete follow-up visits over 18 months to measure your pain levels, knee function, quality of life, and any side effects using questionnaires and pain scales.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
Poland